Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.
Cities are getting fewer doses than expected due federal government’s new split-dose strategy.
The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.
The FDA has authorized a new administration method that splits a single Jynneos vial to vaccinate five people.
After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
The potentially lifesaving prescription drug buprenorphine is less available to women and Black and Latino people with opioid addiction.
The FDA is investigating the source of an outbreak that has led to 12 hospitalizations.
A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.
The coalition of African-American and Latino churches also supports the FDA’s proposed ban on menthol cigarettes and flavored cigars.
The diagnostic test can provide results in less than three minutes.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
The FDA says three types of ONE brand condoms, which were launched in 2004, can now be marketed as “safe and effective” for anal sex.
LGBTQ community centers team with the ADVANCE study to research blood donor eligibility and HIV risk. Participants wanted!
Hepatitis of unknown cause (HUC) was the source of an outbreak linked to bottled alkaline water; 21 people got sick and one died.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.